Archive for April 2023
North End restaurant owners brace for no outdoor dining come May 1
Some neighborhood restaurateurs say that after May 1, customers will inevitably go to competitors who are able to offer outdoor dining, resulting in a loss of business and less jobs for summer staff in the North End. Read More
Read More‘Beantown Beanfest’ to support legal clinics for underrepresented entrepreneurs
A Boston-based legal foundation has ambitions to establish free corporate legal aid clinics across New England for underrepresented founders. To help raise awareness and funds for these plans, the organization is hosting an event celebrating a food historically connected with Boston: beans. Read More
Read MoreBizSpotlight: CM Shredders / Schutte Hammermill
In 2020, the world’s largest buyer of waste, China Read More
Read MoreMedMinder switches CEOs for second time in less than two years
Norwood-based MedMinder Systems Inc. has named a new CEO just over a year since the smart pill dispenser maker had appointed Mike Edwards as its leader. Read More
Read MoreFive things you need to know, and advice for a future rat czar
Today is National Administrative Professionals Day, so be extra nice to the EAs in your life. Here are the five things you need to know in Boston business news to start your workday, plus rats in Boston. Read More
Read MoreAlnylam co-founder’s startup reveals $270M in funding
Seven months after launching with backing from Arch and Andreessen Horowitz, Orbital Therapeutics is revealing exactly how much capital it has — and how it plans to use it. Read More
Read MoreEditorial: Blue Line changes hurt restaurant workers
Anyone who commutes into Boston on public transit has experienced the delays, the slow zones and the service interruptions. But with the latest sudden changes to service on the Red Line and the Blue Line, the T has placed an even greater burden on workers. Read More
Read MoreAerospace sales drive Raytheon’s Q1 profits
The Arlington company also reported a record backlog of orders and offered new details on a planned restructuring. Read More
Read MoreCambridge Trust sees slight decline in loans in Q1
The merger with Northmark expanded Cambridge Trust’s presence into affluent markets such as North Andover, Andover, and Winchester. Read More
Read MoreBiogen’s ALS drug granted accelerated approval by the FDA
On Tuesday, Biogen said the FDA had approved the drug — which will be marketed under the name Qalsody — to treat ALS patients with a mutation in SOD1 gene. Read More
Read More